- Category
- Micro (2021-22)
- Udyam number
- UDYAM-DL-03-0015069

Hipace Pharmaceutical Private Limited
About Hipace Pharmaceutical Private Limited
Data last updated:
Hipace Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 September 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51397DL2020PTC369413.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saudan Singh and Simpi Pal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F/F Rz L – 9/287 Khno – 287 Gali No 5 Pole No66 Geetanjali Park West Sagarpur, Delhi, India – 110046.
As per the financials filed for FY 2024, the company reported a revenue of ₹24.41 Lakh, a growth of 99% compared to the previous year. For the same year it recorded a net loss of ₹11,904 (net margin -0.5%) and EBITDA of -₹7,374 (EBITDA margin -0.3%).
Hipace Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0015069).
Company details
Recognitions & Rankings of Hipace Pharmaceutical
Contact details
Hipace Pharmaceutical Private Limited's registered office is in Delhi, Delhi.
- Registered AddressF/F Rz L – 9/287 Khno – 287 Gali No 5 Pole No66 Geetanjali Park West Sagarpur, Delhi, India – 110046
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hipace Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Hipace Pharmaceutical Private Limited, buy the company report.
Financials of Hipace Pharmaceutical Private Limited
FY 2025 filings availableHipace Pharmaceutical Private Limited reported revenue of ₹24.41 Lakh (up 99% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 99% in the latest year. EBITDA rose 90% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹7,374 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹11,904 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -0.3% | |||
| Net Profit Margin | -0.5% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Hipace Pharmaceutical Private Limited, buy the company report.
Board of directors of Hipace Pharmaceutical Private Limited
Hipace Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saudan Singh | Director | 07 Sep 2020 | 6 Years 1 Months | Current |
| Simpi Pal | Director | 07 Sep 2020 | 6 Years 1 Months | Current |
Peer comparison
Hipace Pharmaceutical Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sanmak Pharmaceuticals Private Limited | ₹24.48 Lakh (FY 2019) | Haridwar, Uttarakhand, India | ||||
| Rohan Pigments P Ltd | ₹24.46 Lakh (FY 2025) | -3.0% | Dombivli, Maharashtra, India | |||
| Naipunyaaayurvedics Private Limited | ₹24.46 Lakh (FY 2024) | 44.0% | Kollam, Kerala, India | |||
| Velanutrition Nutraceuticals Private Limited | ₹24.45 Lakh (FY 2025) | 5077.0% | Udhampur, Jammu and Kashmir, India | |||
| Cure Mantra Herbs Private Limited | ₹24.42 Lakh (FY 2025) | -7.0% | New Delhi, Delhi, India | |||
| Hipace Pharmaceutical Private Limitedthis company | ₹24.41 Lakh (FY 2024) | -₹11,904 | -0.5% | 99.0% | Delhi, India | |
| Amtrack Laboratories Pvt Ltd | ₹24.4 Lakh (FY 2025) | 12.0% | Mumbai, Maharashtra, India | |||
| Clonz Biotech Private Limited | ₹24.39 Lakh (FY 2025) | -67.0% | Hyderabad, Telangana, India | |||
| Parosha Chemicals Private Limited | ₹24.38 Lakh (FY 2023) | 326.0% | Vadodara, Gujarat, India | |||
| Garrix Pharma Private Limited | ₹24.35 Lakh (FY 2024) | 59.0% | New Delhi, Delhi, India | |||
| Nikit Chem Retails Private Limited | ₹24.32 Lakh (FY 2024) | 131.0% | Ludhiana, Punjab, India |
To see the full peer comparison of Hipace Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hipace Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hipace Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hipace Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hipace Pharmaceutical Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Saudan Singh was appointed as Director on 07 Sep 2020.
Frequently asked questions
Hipace Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 September 2020 (6+ years old) and is registered under CIN U51397DL2020PTC369413.
Hipace Pharmaceutical has 2 current directors:
- Saudan Singh - Director
- Simpi Pal - Director
The latest financial statements of Hipace Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Hipace Pharmaceutical is U51397DL2020PTC369413. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hipace Pharmaceutical was incorporated on 07 September 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Hipace Pharmaceutical by revenue are Sanmak Pharmaceuticals Private Limited, Rohan Pigments P Ltd, Naipunyaaayurvedics Private Limited, Velanutrition Nutraceuticals Private Limited, Cure Mantra Herbs Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Saudan Singh was appointed as Director on 07 Sep 2020. Simpi Pal was appointed as Director on 07 Sep 2020.
Yes, Hipace Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0015069).
The registered office of Hipace Pharmaceutical is at FF Rz L – 9287 Khno – 287 Gali No 5 Pole No66 Geetanjali Park West Sagarpur, Delhi, India – 110046.
Hipace Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Hipace Pharmaceutical can be reached at its registered office: FF Rz L – 9287 Khno – 287 Gali No 5 Pole No66 Geetanjali Park West Sagarpur, Delhi, India – 110046.

